The thrust of our mission is to transform patient care through small molecule therapeutics with potential for impact on a global scale. Despite advances in genomics, structural biology, and other scientific disciplines, 90 percent of the proteins in the body that are known to cause disease remain...
The severity of chronic HCV infection was defined by the degree of fibrosis using the METAVIR scoring system: no fibrosis (F0), portal fibrosis without septa (F1), portal fibrosis with few septa (F2), numerous septa without fibrosis (F3), and cirrhosis (F4). Patients with mild or moderate...